Executive Director, Hematology Value & Access

About this role

Responsibilities

• Supporting the Global (V&A) TA Head, represent Access talent and topics with internal partners and external stakeholders. Internally, drive vision, inspire and provide leadership throughout the Access community (International, Regions, Countries) and with key partners (CPS/International, Development, Biomedical Research, Operations, S&G, Regions and Countries). Externally, represent Novartis in appropriate fora and organizations to drive the Novartis strategic access agenda.
• Developing and operationalizing the Integrated Product Access strategy. Collaborate and partner with TAs, Medical Affairs, Development and Biomedical Research to enhance the value proposition, access strategy and access-relevant evidence packages. Ensure access landscaping and payer evidence requirements are built into TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization.
• Create and champion a compelling and competitive global strategic vision for how Novartis will innovate and expand access through DAs for the benefit of patients, Healthcare Systems, Payers, and Novartis. Active leadership in internal fora - enable broad country insights and alignment and leverage external fora to pressure-test strategies, level of evidence etc. for feasibility and success.
• With the TAs, develop the global integrated product access strategy to deliver product differentiation most relevant to payers (e.g., well-defined target population, clinical endpoints, comparators, outcome measures, utility instruments, Health Economics data), patients, and HCS stakeholders worldwide.
• With CLS DAs & Pricing team, (co-)create the international pricing strategy and guidance. With CLS DAs, generate payer negotiation strategy, upskill and prepare countries for their payer negotiations. With CLS DAs, create innovative patient access and contracting approaches, Managed Entry Agreements (MEAs) and Patient Support Programs (PSPs) as required, to improve patient outcomes and support healthcare system affordability.
• Ensure that at launch, Novartis brands are supported by a robust payer value proposition particularly featuring core elements; ‘Value for money’ story, strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis.
• Ensure access team develops and represents expert value evidence input into TPPs, clinical programs (including IEPs), BD&Ls, and develop any additional non-registration evidence to meet the needs of medical experts and institutions involved in reimbursement & access decisions for key geographies. Collaborate with the HEOR & PCO team to ensure full integration of adequate HEOR/evidence deliverables in high quality cross-franchise strategy. Ensure appropriate focus on priority markets needs into overall strategy.
• Determine payer evidence requirements, risks/opportunities in the access landscape and create compelling access strategy with the TA and provide the “access toolbox” to share with priority markets, major HTA architypes and Budget Impact architypes. Ensure appropriate and timely access input into BD&Ls, asset maximization incl. indication sequencing.
• Maximize value of Novartis assets by creating and executing, together with TAs & pricing team, winning pricing strategies. Responsible for building and continually enhancing best-in-class Access capabilities to establish and retain competitive advantage in a dynamic market environment. Provide best-in-class talent attraction, retention, development and coaching to own team and across access and peer community.
• Reporting of technical complaints / adverse events / special case scenarios related to Novartis products within 24 hours of receipt. Distribution of marketing samples (where applicable)

Requirements

• Education: MBA, Ph.D., M.D. or RPh.
• 7+ years of experience in market access roles
• from pharma.
• 5+ years global or ex-US regional experience.
• Experience working early in drug development lifecycle.
• Product launch experience.
• Cross functional and matrix influential experience across a team of multiple stakeholders.
• Experience in driving commercial strategy driven through access or HEOR or pricing expertise.
• Proficient English, both written and spoken.
• Desirable Requirements:
• 10+ years of experience in market access role from Pharma.
• Hematology therapeutic area experience.